Almondz Global Securities Limited

Financial Services — Capital Markets · NSE

₹19.69−₹0.17 (−0.86%)

DalalBaazaar Score

75 / 100

🟢 Good

Verdict

REASONABLE

Risk

Moderate

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: Reasonable but unspectacular business quality, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:00 pm

Understanding the Business

Company site ↗

The 60-second version of Almondz Global Securities Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Almondz Global Securities Limited provides professional advisory and consultancy services in India.

IndustryCapital Markets

SectorFinancial Services

Employees115

Annual revenue₹186 Cr

How does it make money?

Turns over ₹186 Cr a year. Of every ₹100 of sales, about ₹15 reaches shareholders as profit, with ₹22 left at the operating level before interest, tax and depreciation. Each of its 115 employees supports ₹1.62 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹1.62 Cr

Who are its competitors?

The closest listed comparisons in its industry are BAJAJ FINANCE LIMITED, HDFC LIFE INS CO LTD, SBI LIFE INSURANCE CO LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Not assessable from these ratios

For a lender, returns on capital are shaped by leverage and funding cost rather than by pricing power, so the usual financial signature of an advantage does not apply. Judge this one on deposit franchise, cost of funds and asset quality — none of which are in this data.

Peer median ROE13.7%

What has been driving growth?

Growth has come mainly from selling more, rather than from keeping more of each sale. Over 3 years revenue moved +149% while net margin moved -29% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+149%

Margin effect-29%

DalalBaazaar Score

75/ 100

Good

Weighted across six categories. Every point is explained below.

✓ Beta of 0.52 — historically steadier than the index
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

76/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

84/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

10.4x

3Y Median

18.0x

40 monthly readings · mean 18.6x · range 10.8x–36.7x

Sector Median

58.4x

median of 3 sector peers

🟢Current valuation is approximately 42% below its 3y median of 18.0x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 82% below the peer median of 58.4x.

vs. its own history

Cheap

18.0x median over 40 months · -42%

vs. sector peers

Cheap

58.4x median of 3 peers · -82%

vs. generic bands

Cheap

Below 15x

EV/EBITDA

10.1x

PEG

0.50

What's Good / What's Bad

🟢 What's Going Well2

Return on capital is rising
ROCE has improved from 9.2% to 11.5%.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

1 item require attention · 1 high

🔴Significant margin compressionFinancial
EBITDA margin has fallen 9.8 points, from 32.0% to 22.2%.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 42% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 82% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Margins are being competed away
EBITDA margin has fallen from 32.0% to 22.2%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 27% a year✓ 35.5% CAGR
Latest reported year was 42.7%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 20%✓ 22.2%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Return on equity stays above 8%✓ 10.3%
For a lender this is the cleanest single read on whether the book is being grown profitably.
4Valuation vs its own median of 18.0x✓ 10.4x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

8 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

6 good · 4 neutral · 1 weak

Market Cap

₹377 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

10.4x

Cheap

Cheap against the generic band

P/B Ratio

1.31x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹1.9

Profitable

Profitable on a per-share basis

ROE

10.3%

Moderate

Moderate capital efficiency

ROCE

11.5%

Moderate

Moderate return on the capital in the business

Debt/Equity

0.17x

Low

Conservative leverage

Revenue Growth (YoY)

42.7%

Healthy

Healthy top-line growth

Profit Growth (YoY)

70.0%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹6 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

Operating Margin

18.4%

Good

Healthy core-business profitability

Net Margin

16.7%

Good

Strong bottom-line conversion

Current Ratio

2.64

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.52

Defensive

Steadier than the market

52W Range Position

80%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

19.6 / 17.6

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

35.5

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹75 Cr	₹112 Cr	₹148 Cr	₹186 Cr	+35.5%
EBITDA	₹24 Cr	₹26 Cr	₹27 Cr	₹41 Cr	+20.0%
EBITDA Margin	32.0%	23.4%	18.5%	22.2%	—
PAT (Net Profit)	₹16 Cr	₹34 Cr	₹17 Cr	₹28 Cr	+20.7%
EPS	₹0.97	₹1.16	₹1.02	₹1.63	+19.0%
ROE	7.5%	15.5%	7.2%	10.3%	—
ROCE	9.2%	16.5%	8.9%	11.5%	—
Total Debt	₹21 Cr	₹23 Cr	₹53 Cr	₹49 Cr	+34.0%
Free Cash Flow	-₹16 Cr	₹29 Cr	-₹14 Cr	-₹6 Cr	—

🟢 Revenue has grown at 35.5% a year over 3 years.

🟢 EBITDA has grown at 20.0% a year over 3 years.

🔴 EBITDA Margin has fallen from 32.0% to 22.2% over 3 years (-9.8 pts).

🟢 PAT (Net Profit) has grown at 20.7% a year over 3 years.

🟢 EPS has grown at 19.0% a year over 3 years.

🟢 ROE has risen from 7.5% to 10.3% over 3 years (+2.8 pts).

🟢 ROCE has risen from 9.2% to 11.5% over 3 years (+2.4 pts).

🔴 Total Debt has grown at 34.0% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹384 Cr

Total Liabilities

₹90 Cr

Cash & Equivalents

₹6 Cr

Operating Cash Flow

-₹4 Cr

Capex

-₹2 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

70.5%

Corporate Actions

Ex-Dividend Date

15 Sept 2011

Peer Comparison

Company	P/E	ROE
BAJAJ FINANCE LIMITED	30.2x	17.8%
HDFC LIFE INS CO LTD	58.4x	11.3%
SBI LIFE INSURANCE CO LTD	63.9x	13.7%

Recent News

1 mixed5 general

Almondz Global Securities Upper Circuit Today: Price, Data and Peers

Univest, 13 Oct

Almondz Global Securities (ALMONDZ.NS) Climbs 2.84% to ₹19.55, Nears Key Resistance - Fibonacci Time Zone

siam.in, 06 Oct

Almondz Global Securities Ltd. Peer Comparison – Compare with Others

Value Research, 31 Aug

20 Best Stocks Under 50 Rs In India October 2026 For High Returns

Samco, 13 Oct

Innovative Money Matters adds 110,000 Almondz Global shares

scanx.trade, 07 Sept

Almondz Global Securities Share Price Target 2027 to 2030: Analys

Univest, 17 AugAnalyst view

🟡Mixed / dependsBroker commentary — an opinion about the price rather than new information about the business.

Watch Items

This is a financial-sector business: borrowing is its raw material, not leverage in the usual sense. Debt/Equity and ROCE here aren't comparable to a manufacturer's — read them alongside NIM, GNPA and capital adequacy from the company's own disclosures.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Growth · Profitability · Valuation

WeakRisk

Points for each in the Score ↑

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last. 1 high-severity red flag sits above this conclusion and should be read first.

All 4 tripwires holding · see Key things to watch ↑